The emerging role of phosphate in vascular calcification

Slides:



Advertisements
Similar presentations
Volume 69, Issue 1, Pages (January 2006)
Advertisements

Volume 73, Issue 1, Pages 3-5 (January 2008)
Volume 82, Issue 1, Pages 7-8 (July 2012)
Dylan Burger, Adeera Levin  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
John P. Middleton, Patrick H. Pun  Kidney International 
Verotoxin biology: molecular events in vascular endothelial injury
Volume 85, Issue 3, Pages (March 2014)
Volume 73, Issue 9, Pages (May 2008)
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 66, Pages S13-S17 (September 2004)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
Volume 79, Pages S20-S23 (April 2011)
Veerle P. Persy, Marc D. McKee  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Volume 87, Issue 2, Pages (February 2015)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Bisphosphonate safety and efficacy in chronic kidney disease
Volume 83, Issue 5, Pages (May 2013)
Vitamin D receptor: A highly versatile nuclear receptor
Jouni Uitto, Qiaoli Li, Qiujie Jiang 
Volume 70, Issue 12, Pages (December 2006)
Volume 73, Issue 12, Pages (June 2008)
Macrophages and hypoxia in human chronic kidney disease
Volume 67, Pages S51-S58 (June 2005)
Novel phosphate binders: plus ça change, plus c’est la même chose
A physician's perseverance uncovers problems in a key nephrology study
Günter Weiss, Florian Kronenberg  Kidney International 
Volume 83, Issue 5, Pages (May 2013)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
Volume 74, Issue 8, Pages (October 2008)
Calcium sensing in podocytes
Atrial fibrillation in end-stage renal disease: an emerging problem
Volume 56, Issue 4, Pages (October 1999)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Volume 75, Issue 9, Pages (May 2009)
Fibroblast growth factor 23: the making of a hormone
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Should the targeted value of the phosphate be reviewed in the normal range from the viewpoint of vascular calcification?  Keitaro Yokoyama, Hiraku Yoshida,
Nanocrystals seed calcification in more ways than one
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 72, Issue 2, Pages (July 2007)
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 69, Issue 1, Pages (January 2006)
Volume 73, Issue 8, Pages (April 2008)
Is it the low-protein diet or simply the salt restriction?
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Volume 71, Issue 9, Pages (May 2007)
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
Volume 75, Issue 6, Pages (March 2009)
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
The international realities of live donor kidney transplantation
Volume 74, Issue 11, Pages (December 2008)
Cell biological and physicochemical aspects of arterial calcification
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Vascular calcification: Not so crystal clear
The Ebf1 knockout mouse and glomerular maturation
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in.
Sclerostin and DKK1: new players in renal bone and vascular disease
Presentation transcript:

The emerging role of phosphate in vascular calcification Cecilia M. Giachelli  Kidney International  Volume 75, Issue 9, Pages 890-897 (May 2009) DOI: 10.1038/ki.2008.644 Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 1 Major mechanisms of vascular calcification. Six different mechanisms that have been proposed to regulate the initiation or progression of vascular calcification are illustrated, along with key molecular mediators where known. The extent to which each of these mechanisms plays a role in vascular calcification in various disease states, including hyperphosphatemia and ESRD, is currently unknown. cMGP; gamma carboxylated matrix gla protein, pOPN; phosphorylated osteopontin. Kidney International 2009 75, 890-897DOI: (10.1038/ki.2008.644) Copyright © 2009 International Society of Nephrology Terms and Conditions

Figure 2 Proposed role of elevated phosphate (Pi) in osteochondrogenic phenotype change and matrix mineralization in vascular SMC. Pi enters the cell through the sodium-dependent phosphate cotransporter, Pit-1, and induces an osteochondrogenic phenotype change. This stimulates matrix vesicle calcium and Pi loading, as well as matrix changes that promote calcification. Molecules involved in regulating Pi loading of matrix vesicles or Pi efflux are currently unknown. Kidney International 2009 75, 890-897DOI: (10.1038/ki.2008.644) Copyright © 2009 International Society of Nephrology Terms and Conditions